Overview
Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro
Eligibility
Inclusion Criteria:
- Diagnosis of MPN in the participating center
- Over 18 yo
Exclusion Criteria:
- Not able to consent
Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
Recruiting
18 years and older
All
Phase N/A
Study details
Myeloproliferative Neoplasm
NCT06462664
University Hospital, Brest
26 June 2024
Step
1
Get in touch with the nearest study center
,
Your Information has been sent successfully.
Send a message
Enter your contact details to connect with study team
Primary Contact
Other languages supported:
FAQs
Learn more about clinical trials
What is a clinical trial?
A clinical trial is a study designed to test specific
interventions or treatments' effectiveness and safety,
paving the way for new, innovative healthcare solutions.
Why should I take part in a clinical trial?
Participating in a clinical trial provides early access to
potentially effective treatments and directly contributes to
the healthcare advancements that benefit us all.
How long does a clinical trial take place?
The duration of clinical trials varies. Some trials last
weeks, some years, depending on the phase and intention of
the trial.
Do I get compensated for taking part in clinical trials?
Compensation varies per trial. Some offer payment or
reimbursement for time and travel, while others may not.
How safe are clinical trials?
Clinical trials follow strict ethical guidelines and
protocols to safeguard participants' health. They are
closely monitored and safety reviewed regularly.
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.